Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.18
Oct 29 • 3:59 PM ET Dollar change-0.01 Percentage change(-0.84%)
Aftermarket Close
1.18
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
25.58M
Enterprise Value
12.92M
Income
-29.28M
Sales
168.86M
Book/sh
1.06
Cash/sh
0.60
Employees
189
IPO
Apr 26, 1999
P/E
-
Forward P/E
-
PEG
-
P/S
0.15
P/B
1.11
P/C
1.96
P/FCF
-
EV/EBITDA
-
EV/Sales
0.08
Quick Ratio
0.47
Current Ratio
0.68
Debt/Eq
0.02
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-1.39
EPS next Y
-0.35
EPS next Q
-0.11
EPS this Y
81.75%
EPS next Y
30.00%
EPS next 5Y
49.64%
EPS past 3/5Y
- -
Sales past 3/5Y
-11.31% -10.35%
EPS Y/Y TTM
34.91%
Sales Y/Y TTM
-19.67%
EPS Q/Q
82.78%
Sales Q/Q
-19.86%
Insider Own
33.61%
Insider Trans
0.34%
Inst Own
21.90%
Inst Trans
-8.41%
ROA
-33.73%
ROE
-78.56%
ROIC
-127.36%
Gross Margin
22.44%
Oper. Margin
-18.22%
Profit Margin
-17.34%
SMA20
-4.12%
SMA50
-21.03%
SMA200
-44.46%
Trades
Shs Outstand
21.68M
Shs Float
14.39M
52W High
4.10 -71.22%
52W Low
1.15 2.61%
Volatility
4.94% 3.63%
ATR (14)
0.05
RSI (14)
31.97
Beta
0.82
Rel Volume
0.11
Avg Volume
109.92K
Volume
12,520
Perf Week
0.00%
Perf Month
-14.49%
Perf Quarter
-39.49%
Perf Half Y
-47.32%
Perf YTD
-63.13%
Perf Year
-54.44%
Perf 3Y
-87.39%
Perf 5Y
-95.85%
Perf 10Y
-94.06%
Prev Close
1.19
Price
1.18
Change %
-0.84%
Consensus
Strong Sell
Avg. Price Target
$1.40
Implied Upside
+18.6%
Analysts9incl. previous ratings
Rating Distribution4 Buy · 3 Hold · 2 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 25, 2023Initiated
LLake Street
Buy$20+1,594.9%
Jan 20, 2022Upgrade
SSidoti
Neutral → Buy$32+2,611.9%
Nov 18, 2021Initiated
MS logoMMorgan Stanley
Underweight$25+2,018.6%
Oct 01, 2021Initiated
JEF logoJJefferies
Hold$28+2,272.9%
Aug 05, 2021Resumed
CCredit Suisse
Underperform$22+1,764.4%
Jun 03, 2021Downgrade
SSidoti
Buy → Neutral$39+3,205.1%
Mar 05, 2021Upgrade
SSidoti
Neutral → Buy
Jan 27, 2021Downgrade
SSidoti
Buy → Neutral
Aug 19, 2020Upgrade
SSidoti
Neutral → Buy$37 → $41+3,374.6%
Apr 09, 2020Downgrade
SSidoti
Buy → Neutral
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NINA CAPITAL HOLDINGS INC.10% OwnerJun 08 '26Buy1.7525,00043,7252,600,000Jun 09 05:06 PM
PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs, cats, and horses. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Chief Accounting OfficerMr. Douglas Krulik
Strategic AdvisorMs. Leslie C. G. Campbell
CEOMr. Jeffrey Allen Willard
Chief Technology OfficerMr. Andrew Parry
Corporate Secretary & General CounselMr. Robert Lawsky